10x Genomics (TXG) Cash from Investing Activities Growth (3y) (2021 - 2026)

10x Genomics (TXG) Cash from Investing Activities Growth (3y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Veeva Systems 24.83 Bn 17.52 Bn 662.02 Mn -9.34%
2 BrightSpring Health Services 13.57 Bn 12.69 Bn 482.22 Mn 255.16%
3 Healthequity 7.20 Bn 6.93 Bn 256.31 Mn -15.03%
4 Hinge Health 5.42 Bn 5.11 Bn 154.23 Mn -
5 10x Genomics 4.46 Bn 3.92 Bn 106.18 Mn -26.22%
6 Doximity 3.81 Bn 3.06 Bn 125.97 Mn 131.77%
7 Waystar Holding 3.52 Bn 3.36 Bn 268.04 Mn -
8 Privia Health 2.94 Bn 2.57 Bn 595.71 Mn 89.85%
9 Omnicell 1.76 Bn 1.59 Bn 140.36 Mn -5.17%
10 Teladoc Health 1.45 Bn 696.57 Mn 562.57 Mn 7.15%

Historic Data

Download Data
DateValue
Mar 31, 2026 -26.22%
Dec 31, 2025 62.11%
Sep 30, 2025 35.39%
Jun 30, 2025 67.57%
Mar 31, 2025 80.56%
Dec 31, 2024 -23.16%
Sep 30, 2024 43.66%
Jun 30, 2024 41.28%
Mar 31, 2024 30.84%
Dec 31, 2023 37.30%
Sep 30, 2023 79.05%
Jun 30, 2023 12.84%
Mar 31, 2023 156.36%
Dec 31, 2022 -71.46%
Sep 30, 2022 -33.62%
Jun 30, 2022 -27.95%
Mar 31, 2022 -201.83%
Dec 31, 2021 -113.72%